Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
Rolim I, Henriques V, Rolim N, et al. Clinicopathologic analysis of upper urinary tract carcinoma with variant histology. Virchows Arch. 2020;477(1):111–20.
Article PubMed CAS Google Scholar
Terada T. Urinary bladder carcinoma with triplicate differentiations into giant cell sarcomatoid carcinoma, squamous cell carcinoma, and papillary urothelial transitional cell carcinoma: a case report. Cases J. 2009;2:9111.
Article PubMed PubMed Central Google Scholar
Yaldiz M, Cosansu NC, Solak B, et al. Synchronous papillary urothelial carcinoma of the bladder and squamous cell carcinoma with sarcomatoid differentiation: a case report. Oncol Lett. 2016;12(5):3475–7.
Article PubMed PubMed Central Google Scholar
Yavuzsan AH, Yesildal C, Kirecci SL, et al. Radical cystectomy and Ileal Conduit diversion for bladder Urothelial Carcinoma with Sarcomatoid and squamous variants after renal transplantation. Cureus. 2020;12(5):e7935.
PubMed PubMed Central Google Scholar
Attia A, Siriwardana A, Desai D. Sarcomatoid urothelial carcinoma of the ureter with heterologous elements of chondrosarcoma and osteosarcoma, and concurrent divergent squamous differentiation: a rare case report. Urol Case Rep. 2020;34:101484.
Article PubMed PubMed Central Google Scholar
Ren S, Feng H, Bao Y, et al. Ureteral urothelial carcinoma with squamous cell carcinoma and sarcomatoid carcinoma differentiation: a case report. BMC Surg. 2021;21(1):96.
Article PubMed PubMed Central Google Scholar
Fikri J, Almalki AM, Almalki SA, et al. Upper urinary tract Urothelial Carcinoma with squamous, glandular, and Sarcomatoid variants in a horseshoe kidney: a Novel Case Report and Literature Review. Cureus. 2021;13(11):e19627.
PubMed PubMed Central Google Scholar
Kumar Pal A, Srinivas BH, Kalra S, et al. Sarcomatoid Urothelial Carcinoma of the urinary bladder with Chondrosarcomatous and concurrent divergent squamous cell carcinoma Differentiation- A Rare Entity. Cureus. 2022;14(12):e33107.
PubMed PubMed Central Google Scholar
Antonov P, Raycheva G, Ivanov G, et al. Hybrid bladder tumor: Urothelial Carcinoma with squamous cell differentiation, Urothelial Sarcomatoid Carcinoma, and concurrent primary mucinous adenocarcinoma with metastasis to the Penis. Cureus. 2024;16(9):e68894.
PubMed PubMed Central Google Scholar
Cowan NC, Turney BW, Taylor NJ, et al. Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour. BJU Int. 2007;99(6):1363–70.
Janisch F, Shariat SF, Baltzer P, et al. Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis. World J Urol. 2020;38(5):1165–75.
Razavi SA, Sadigh G, Kelly AM, et al. Comparative effectiveness of imaging modalities for the diagnosis of upper and lower urinary tract malignancy: a critically appraised topic. Acad Radiol. 2012;19(9):1134–40.
Takahashi N, Glockner JF, Hartman RP, et al. Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy. J Urol. 2010;183(4):1330–65.
Messer J, Shariat SF, Brien JC, et al. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int. 2011;108(5):701–5.
Subiela JD, Territo A, Mercadé A, et al. Diagnostic accuracy of ureteroscopic biopsy in predicting stage and grade at final pathology in upper tract urothelial carcinoma: systematic review and meta-analysis. Eur J Surg Oncol. 2020;46(11):1989–97.
Sharma V, Miest TS, Juvet TS, et al. The impact of Upper Tract Urothelial Carcinoma Diagnostic modality on Intravesical recurrence after Radical Nephroureterectomy: a single Institution Series and updated Meta-analysis. J Urol. 2021;206(3):558–67.
Mori K, Janisch F, Parizi MK, et al. Prognostic value of variant histology in Upper Tract Urothelial Carcinoma Treated with nephroureterectomy: a systematic review and Meta-analysis. J Urol. 2020;203(6):1075–84.
Tang Q, Xiong G, Li X, et al. The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy. World J Urol. 2016;34(6):871–7.
Article PubMed CAS Google Scholar
Wang X, MacLennan GT, Zhang S, et al. Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization. Hum Pathol. 2009;40(2):211–7.
Article PubMed CAS Google Scholar
Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma collaboration. Cancer. 2009;115(6):1224–33.
Kondo T, Nakazawa H, Ito F, et al. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J Urol. 2007;178(4 Pt 1):1212–7.
Dominguez-Escrig JL, Peyronnet B, Seisen T, Bruins HM, et al. Potential benefit of Lymph Node Dissection during Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a systematic review by the European Association of Urology Guidelines Panel on non-muscle-invasive bladder Cancer. Eur Urol Focus. 2019;5(2):224–41.
Rouprêt M, Seisen T, Birtle AJ, et al. European Association of Urology Guidelines on Upper urinary tract Urothelial Carcinoma: 2023 update. Eur Urol. 2023;84(1):49–64.
Margulis V, Puligandla M, Trabulsi EJ, et al. Phase II trial of Neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high Grade Upper Tract Urothelial Carcinoma. J Urol. 2020;203(4):690–8.
Meng X, Chao B, Vijay V, et al. High response rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma. Urology. 2019;129:146–52.
Coleman JA, Yip W, Wong NC, et al. Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for patients with high-Grade Upper Tract Urothelial Carcinoma. J Clin Oncol. 2023;41(8):1618–25.
Article PubMed PubMed Central CAS Google Scholar
Leow JJ, Chong YL, Chang SL, et al. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: a 2020 systematic review and Meta-analysis, and future perspectives on systemic therapy. Eur Urol. 2021;79(5):635–54.
Article PubMed CAS Google Scholar
Birtle AJ, Jones R, Chester J, et al. Improved Disease-Free Survival with Adjuvant Chemotherapy after Nephroureterectomy for Upper Tract Urothelial Cancer: final results of the POUT Trial. J Clin Oncol. 2024;42(13):1466–71.
Article PubMed CAS Google Scholar
Tully KH, Krimphove Md MJ, Huynh MJ, et al. Differences in survival and impact of adjuvant chemotherapy in patients with variant histology of tumors of the renal pelvis. World J Urol. 2020;38(9):2227–36.
Article PubMed CAS Google Scholar
Bajorin DF, Witjes JA, Gschwend JE, et al. Adjuvant Nivolumab versus Placebo in muscle-invasive Urothelial Carcinoma. N Engl J Med. 2021;384(22):2102–14.
Article PubMed PubMed Central CAS Google Scholar
Holmäng S, Lele SM, Johansson SL. Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome. J Urol. 2007;178(1):51–6.
Comments (0)